A nearly 15% increase in service revenue from digital mammography systems was among the contributors to revenue gains for women's imaging vendor Hologic in its fiscal fourth quarter.
For the period (end-September 30), Hologic had revenue of $588.5 million, up 26% from the $467 million reported in the fourth quarter of 2011. The fourth-quarter results included revenue of $89.5 million from its acquisition of Gen-Probe.
Service revenue primarily related to its installed base of digital mammography systems climbed $10.5 million, or 14.5%, during the quarter.
Affected by noncash charges, interest expenses, and acquisition-related costs, Hologic had a net loss of $77.8 million in the quarter, compared with net income of $27.6 million reported in the same period last year.
For the year, Hologic had revenue of $2 billion, up from the $1.8 billion reported in 2011. The company had a net loss for the year of $73.6 million, compared with net income of $157.2 million a year ago.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
